# US 2020/0138029 A1 · Fungicidal oxadiazoles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0138029 A1
- Document ID: US20200138029A1
- Status: Published application
- Kind: A1
- Application number: 16/625,210
- Filed: 2018-07-03
- Published: 2020-05-07
- Earliest claimed: 2017-07-05
- Assignees: FMC Corporation
- Applicants: FMC Corporation
- Inventors: Robert James PASTERIS
- Web page: https://patentgrep.com/patent/US20200138029A1

## CPC

- A01N 43/82: five-membered rings with three ring hetero atoms
- A01N 47/12: containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
- A01N 47/16: the nitrogen atom being part of a heterocyclic ring
- A01N 47/20: N-Aryl derivatives thereof
- C07D 271/06: 1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Disclosed are compounds of Formula 1, including all geometric and stereoisomers, tautomers, N-oxides, and salts thereof, wherein R1, Z1, W, Z2 and J are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

## Claims

### Claim 1

A compound selected from Formula 1, N-oxides, and salts thereof,
R1 is H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C2-C6 alkylcarbonyl or C2-C6 alkoxycarbonyl, each optionally substituted with up to 3 substituents independently selected from R2; or phenyl optionally substituted with up to 3 substituents independently selected from R3a; or a 3- to 7-membered nonaromatic carbocyclic ring, wherein up to 3 carbon atom ring members are independently selected from C(═O) and C(═S), each ring optionally substituted with up to 3 substituents independently selected from R3a; or a 5- to 6-membered heterocyclic ring, each ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, wherein up to 3 carbon atom ring members are independently selected from C(═O) and C(═S), and the sulfur atom ring members are independently selected from S(═O)u(═NR12)v, each ring optionally substituted with up to 5 substituents independently selected from R3a on carbon atom ring members and R3b on nitrogen atom ring members;
Z1 is O, —(CH2)nNR4a—, —(CH2)nNR4aNR4b— or —CH═NNR4b—, wherein the bond projecting to the left is attached to R1, and the bond projecting to the right is attached to C═W;
W is O or S;
Z2 is —O(CH2)m—, —OCH2CH2O— or —NR5N═CH—, wherein the bond projecting to the left is attached to C═W, and the bond projecting to the right is attached to J, each carbon atom optionally substituted with up to 2 substituents independently selected from R6;
J is phenyl optionally substituted with up to 2 substituents independently selected from R7; or a 5- to 6-membered heteroaromatic ring, each ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, wherein up to 2 ring members are independently selected from C(═O), C(═S), S(═O) and S(═O)2, each ring optionally substituted with up to 2 substituents independently selected from R7 on carbon atom ring members and R8 on nitrogen atom ring members;
each R2 is independently halogen, hydroxy, cyano, —S—C≡N, —SH, amino, nitro, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-C4 dialkylamino, C2-C4 alkylcarbonyl, C2-C4 haloalkylcarbonyl, C2-C5 alkoxycarbonyl, C2-C5 haloalkoxycarbonyl, C2-C5 alkylaminocarbonyl or C3-C5 dialkylaminocarbonyl; or phenyl, pyridinyl, pyrazolyl, imidazolyl, triazolyl, thiazolyl, oxazolyl, isoxazolyl, oxetanyl, 1,3-dioxolanyl, tetrahydropyranyl, thienyl, furanyl, pyrrolidinyl, isoxazolinyl, tetrahydrofuranyl, piperidinyl, morpholinyl or piperazinyl, each optionally substituted with up to 3 substituents independently selected from R3c on carbon atom ring members and R3d on nitrogen atom ring members;
each R3a and R3c is independently halogen, hydroxy, cyano, amino, nitro, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 hydroxyalkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, C2-C4 alkoxyalkyl, C2-C6 alkylcarbonyloxy, C1-C4 alkylthio, C1-C4 haloalkylthio, C2-C6 alkylcarbonylthio, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfonyloxy, C1-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl;
each R3b and R3d is independently C1-C3 alkyl, C1-C3 alkoxy, C2-C3 alkylcarbonyl or C2-C3 alkoxycarbonyl;
R4a and R4b are each independently H, hydroxy, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkoxyalkyl, C2-C4 alkylthioalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C2-C4 alkylsulfinylalkyl, C2-C4 alkylsulfonylalkyl, C2-C4 alkylcarbonyl, C2-C4 haloalkylcarbonyl, C2-C5 alkoxycarbonyl, C3-C5 alkoxycarbonylalkyl, C2-C5 alkylaminocarbonyl, C3-C5 dialkylaminocarbonyl, C3-C7 alkylaminocarbonylalkyl or C4-C7 dialkylaminocarbonylalkyl; or
one pair of R1 and R4a substituents or one pair of R1 and R4b substituents are taken together with the atoms to which they are attached to form a 5- to 7-membered ring containing ring members selected from carbon atoms and optionally up to 3 heteroatoms independently selected from up to 1 O, up to 1 S and up to 2 N atoms, wherein up to 3 ring members are independently selected from C(═O), C(═S), S(═O) and S(═O)2, each ring optionally substituted with up to 4 substituents independently selected from R9; or
one pair of R3a and R4a substituents or one pair of R3a and R4b substituents are taken together with the atoms to which they are attached to form a 5- to 7-membered ring containing ring members selected from carbon atoms and optionally up to 3 heteroatoms independently selected from up to 1 O, up to 1 S and up to 2 N atoms, wherein up to 3 ring members are independently selected from C(═O), C(═S), S(═O) and S(═O)2, each ring optionally substituted with up to 4 substituents independently selected from R10; or
one pair of R3b and R4a substituents or one pair of R3b and R4b substituents are taken together with the nitrogen atoms to which they are attached to form a 5- to 7-membered ring containing ring members selected from carbon atoms and optionally up to 3 heteroatoms independently selected from up to 1 O, up to 1 S and up to 2 N atoms, wherein up to 3 ring members are independently selected from C(═O), C(═S), S(═O) and S(═O)2, each ring optionally substituted with up to 4 substituents independently selected from R11;
R5 is H, hydroxy, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkoxyalkyl, C2-C4 alkylthioalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C2-C4 alkylsulfinylalkyl, C2-C4 alkylsulfonylalkyl, C2-C4 alkylcarbonyl, C2-C4 haloalkylcarbonyl, C2-C5 alkoxycarbonyl, C3-C5 alkoxycarbonylalkyl, C2-C5 alkylaminocarbonyl or C3-C5 dialkylaminocarbonyl;
each R6 is independently halogen, hydroxy, cyano, nitro, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy, C1-C2 haloalkoxy or C2-C4 alkoxyalkyl; or phenyl optionally substituted with up to 3 substituents independently selected from R13;
each R7 is independently halogen, hydroxy, cyano, amino, nitro, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 hydroxyalkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy, C2-C4 alkoxyalkyl, C2-C4 alkylcarbonyloxy, C1-C4 alkylthio, C1-C4 haloalkylthio, C2-C4 alkylcarbonylthio, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfonyloxy, C1-C4 alkylamino, C2-C6 dialkylamino, C3-C6 cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C6 dialkylaminocarbonyl or C3-C6 trialkylsilyl;
each R8 is independently C1-C3 alkyl;
each R9, R10 and R11 is independently halogen, hydroxy, cyano, nitro, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkoxyalkyl, C2-C4 alkylthioalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C2-C4 alkylsulfinylalkyl, C2-C4 alkylsulfonylalkyl, C2-C4 alkylcarbonyl, C2-C4 haloalkylcarbonyl, C2-C5 alkoxycarbonyl, C3-C5 alkoxycarbonylalkyl, C2-C5 alkylaminocarbonyl or C3-C5 dialkylaminocarbonyl;
each R12 is independently H, cyano, C1-C3 alkyl or C1-C3 haloalkyl;
each R13 is independently halogen, cyano, amino, nitro, C1-C4 alkyl, C1-C4 haloalkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 hydroxyalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkenyloxy, C2-C4 alkynyloxy or C2-C4 alkoxyalkyl;
n is 0;
m is 1, 2 or 3; and
each u and v are independently 0, 1 or 2 in each instance of S(═O)u(═NR12)v, provided that the sum of u and v is 0, 1 or 2;
provided that:
(a) when J is phenyl or a 6-membered heteroaromatic ring, then J is attached to Z2 and the oxadiazole ring in Formula 1 in a meta- or para-arrangement; and
(b) the compound of Formula 1 is not:
[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl](2-chlorophenyl)]methyl N-(phenylmethyl)carbamate;
[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl](4-chlorophenyl)]methyl N-(phenylmethyl)carbamate;
[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl ester 4-morpholinecarboxylic acid;
[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl acetyl(methyl)carbamate;
[4-[5-(trifluoromethyl)-1,2-3-oxadiazol-3-yl]phenyl]methyl N-methylcarbamate;
[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl N-2-pyridinylcarbamate;
1-[4-[5-(trifluoromethyl)-1,2,3-oxadiazol-3-yl]phenyl]ethyl N,N-dimethylcarbamate;
[4-[5-(trifluoromethyl)-1,2-3-oxadiazol-3-yl]phenyl]methyl N-methoxy-N-methylcarbamate;
[4-[5-(trifluoromethyl)-1,2-3-oxadiazol-3-yl]phenyl]methyl N-(2,2,2-trifluoroethyl)carbamate;
[4-[5-(trifluoromethyl)-1,2-3-oxadiazol-3-yl]phenyl]methyl N-cyclopropylcarbamate; or
[4-[5-(trifluoromethyl)-1,2-3-oxadiazol-3-yl]phenyl]methyl N,N-dimethylcarbamate.

### Claim 2 (depends on 1)

A compound of claim 1 wherein:
R1 is H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C2-C6 alkylcarbonyl or C2-C6 alkoxycarbonyl, each optionally substituted with up to 2 substituents independently selected from R2; or phenyl optionally substituted with up to 3 substituents independently selected from R3a; or a 3- to 7-membered nonaromatic carbocyclic ring, wherein up to 2 carbon atom ring members are independently selected from C(═O) and C(═S), each ring optionally substituted with up to 3 substituents independently selected from R3a; or a 5- to 6-membered heterocyclic ring, each ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, wherein up to 2 carbon atom ring members are independently selected from C(═O) and C(═S), each ring optionally substituted with up to 3 substituents independently selected from R3a on carbon atom ring members and R3b on nitrogen atom ring members;
Z1 is O, —NR4a— or —NR4aNR4b—;
W is O;
Z2 is —O(CH2)m— or —NR5N═CH—, each carbon atom optionally substituted with up to 2 substituents independently selected from R6;
J is phenyl optionally substituted with up to 2 substituents independently selected from R7; or a 5- to 6-membered heteroaromatic ring, each ring containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 2 substituents independently selected from R7 on carbon atom ring members and R8 on nitrogen atom ring members;
each R2 is independently halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkylcarbonyl, C2-C4 haloalkylcarbonyl or C2-C5 alkoxycarbonyl; or phenyl, pyridinyl, pyrazolyl, imidazolyl, triazolyl, pyrrolidinyl, isoxazolinyl, tetrahydrofuranyl, piperidinyl, morpholinyl or piperazinyl, each optionally substituted with up to 2 substituents independently selected from R3c on carbon atom ring members and R3d on nitrogen atom ring members;
each R3a and R3c is independently halogen, cyano, C1-C2 alkyl, C1-C2 haloalkyl, C2-C3 alkenyl, C2-C3 alkynyl, C1-C2 alkoxy, C2-C3 alkenyloxy, C2-C3 alkynyloxy, C2-C4 alkylcarbonyl, C2-C5 alkoxycarbonyl, C2-C5 alkylaminocarbonyl or C3-C7 dialkylaminocarbonyl;
each R3b and R3d is independently C1-C2 alkyl, C1-C2 alkoxy, C2-C3 alkylcarbonyl or C2-C3 alkoxycarbonyl;
R4a and R4b are each independently H, methyl, C1-C2 haloalkyl, methoxymethyl, methylsulfonyl, methylcarbonyl or methoxycarbonyl; or
one pair of R1 and R4a substituents or one pair of R1 and R4b substituents are taken together with the atoms to which they are attached to form a 5- to 6-membered ring containing ring members selected from carbon atoms and optionally up to 3 heteroatoms independently selected from up to 1 O, up to 1 S and up to 2 N atoms, each ring optionally substituted with up to 2 substituents independently selected from R9; or
one pair of R3a and R4a substituents or one pair of R3a and R4b substituents are taken together with the atoms to which they are attached to form a 5- to 6-membered ring containing ring members selected from carbon atoms and optionally up to 3 heteroatoms independently selected from up to 1 O, up to 1 S and up to 2 N atoms, each ring optionally substituted with up to 2 substituents independently selected from R10; or
one pair of R3b and R4a substituents or one pair of R3b and R4b substituents are taken together with the nitrogen atoms to which they are attached to form a 5- to 6-membered ring containing ring members selected from carbon atoms and optionally up to 3 heteroatoms independently selected from up to 1 O, up to 1 S and up to 2 N atoms, each ring optionally substituted with up to 2 substituents independently selected from R11;
R5 is H or methyl;
each R6 is independently halogen, C1-C2 alkyl, C1-C2 haloalkyl, C1-C2 alkoxy or C2-C4 alkoxyalkyl; or phenyl optionally substituted with up to 2 substituents independently selected from R13;
each R7 is independently halogen, methyl, trifluoromethyl or methoxy;
each R8 is independently methyl or ethyl;
each R9, R10 and R11 is independently halogen, hydroxy, cyano, nitro, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; and
each R13 is independently halogen, C1-C2 alkyl, C1-C2 haloalkyl or C1-C2 alkoxy.

### Claim 3 (depends on 2)

A compound of claim 2 wherein:
R1 is H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C2-C6 alkylcarbonyl or C2-C6 alkoxycarbonyl, each optionally substituted with up to 2 substituents independently selected from R2; or R1 is selected from U-1 through U-79
wherein when R3 is attached to a carbon ring member, said R3 is selected from R3a, and when R3 is attached to a nitrogen ring member said R3 is selected from R3b; and k is 0, 1 or 2;
J is selected from J-1 through J-71
wherein the bond projecting to the left is bonded to Z2, and the bond projecting to the right is bonded to the oxadiazole ring in Formula 1; each R7a is independently H or R7; and R8b is H; provided that at most only two of R7a are other than H;
each R2 is independently halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C2-C4 alkylcarbonyl, C2-C4 haloalkylcarbonyl or C2-C5 alkoxycarbonyl;
each R3a is independently halogen, C1-C2 alkyl, C2-C3 alkenyl, C2-C3 alkynyl, C2-C3 alkenyloxy, C2-C3 alkynyloxy, C2-C4 alkylcarbonyl or C2-C5 alkoxycarbonyl;
each R3b is methyl;
R4a and R4b are each independently H or methyl; or
one pair of R1 and R4a substituents are taken together with the atoms to which they are attached to form a pyrazolyl or imidazolyl ring, each ring optionally substituted with up to 2 substituents independently selected from R9;
R5 is H;
each R6 is independently methyl, methoxy or C2-C4 alkoxyalkyl; or phenyl optionally substituted with up to 2 substituents independently selected from R13;
each R7 is independently halogen or methyl;
each R9 is independently halogen, hydroxy, C1-C2 alkyl, C1-C2 haloalkyl or C1-C2 alkoxy; and
R13 is halogen or methyl.

### Claim 4 (depends on 3)

A compound of claim 3 wherein:
R1 is H; or C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C4 alkylcarbonyl or C2-C4 alkoxycarbonyl, each optionally substituted with up to 1 substituent selected from R2; or U-36, U-37, U-38, U-39, U-41, U-50, U-53, U-55 or U-58;
Z1 is —NR4a—;
J is J-40, J-50, J-51 or J-52;
R2 is halogen, cyano, C1-C3 alkyl, C1-C3 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy;
each R3a is independently halogen, C1-C2 alkyl, C2-C4 alkylcarbonyl or C2-C5 alkoxycarbonyl;
R4a is H; or
one pair of R1 and R4a substituents are taken together with the atoms to which they are attached to form an imidazolyl ring, the ring optionally substituted with up to 2 substituents independently selected from R9;
each R6 is independently methyl or CH3OCH2; or phenyl optionally substituted with up to 1 substituent selected from R13;
each R7 is independently Cl, F or methyl; and
each R9 is independently F, Cl, methyl or methoxy.

### Claim 5 (depends on 4)

A compound of claim 4 wherein:
R1 is H; or C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C2-C4 alkylcarbonyl or C2-C4 alkoxycarbonyl, each optionally substituted with up to 1 substituent selected from R2; or U-50;
Z2 is —O(CH2)m—;
J is J-50;
R2 is halogen, cyano, C1-C3 alkyl or C1-C3 alkoxy;
each R3a is independently Br, Cl, F, methyl, C2-C4 alkylcarbonyl or C2-C4 alkoxycarbonyl;
R4a is H;
each R7a is H; and
m is 1 or 2.

### Claim 6 (depends on 1)

A compound of claim 1 which is selected from the group:
[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl]phenyl]methyl carbamate (Compound 17);
[6-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl]-3-pyridinyl]methyl] carbamate;
[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl]-2-pyridinyl]methyl] carbamate;
[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl]-2-thienyl]methyl] carbamate;
1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-
3-yl]phenyl]ethyl N-3-pyridinyl-carbamate
(Compound 23);
2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-
3-yl]phenyl]ethyl N-ethylcarbamate
(Compound 43); and
methyl 2-[[4-[5-(trifluoromethyl)-1,2,4-
oxadiazol-3-yl]phenyl]methylene]-
hydrazinecarboxylate (Compound 105).

### Claim 7 (depends on 1)

A fungicidal composition comprising (a) a compound of claim 1; and (b) at least one other fungicide.

### Claim 8 (depends on 1)

A fungicidal composition comprising (a) a compound of claim 1; and (b) at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.

### Claim 9 (depends on 1)

A method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed, a fungicidally effective amount of a compound of claim 1.

### Claim 10 (depends on 1)

A method for controlling plant diseases caused by Basidiomycetes fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed, a fungicidally effective amount of a compound of claim 1.
